
Sanofi SNY
$ 47.48
0.35%
Annual report 2024
added 02-14-2026
Sanofi Operating Cycle 2011-2026 | SNY
Annual Operating Cycle Sanofi
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | 330 | 311 | 314 | 308 | 307 | 286 |
All numbers in EUR currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 330 | 286 | 309 |
Operating Cycle of other stocks in the Biotechnology industry
| Issuer | Operating Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Acasti Pharma
ACST
|
1.97 | - | 4.01 % | $ 150 M | ||
|
AgeX Therapeutics
AGE
|
78.4 | - | -10.17 % | $ 12.2 K | ||
|
AIkido Pharma
AIKI
|
17.9 | - | 1.93 % | $ 17.4 M | ||
|
I-Mab
IMAB
|
271 | - | - | $ 866 M | ||
|
Aptorum Group Limited
APM
|
4.89 | $ 0.81 | 0.15 % | $ 4.42 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
12.8 | - | - | $ 40.3 B | ||
|
Albireo Pharma
ALBO
|
40.8 | - | -0.23 % | $ 916 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
32 | - | -1.52 % | $ 24.7 M | ||
|
Midatech Pharma plc
MTP
|
245 | - | -18.52 % | $ 27.3 M | ||
|
BioMarin Pharmaceutical
BMRN
|
819 | $ 61.58 | -1.66 % | $ 11.7 B | ||
|
Acorda Therapeutics
ACOR
|
394 | - | -24.86 % | $ 820 K | ||
|
Институт стволовых клеток человека
ISKJ
|
104 | - | - | - | ||
|
Axsome Therapeutics
AXSM
|
273 | $ 165.14 | -2.83 % | $ 8.22 B | ||
|
Ayala Pharmaceuticals
AYLA
|
61.7 | - | - | $ 7.46 M | ||
|
CASI Pharmaceuticals
CASI
|
135 | $ 0.31 | -61.59 % | $ 42.2 M | ||
|
Alpine Immune Sciences
ALPN
|
154 | - | - | $ 2.17 B | ||
|
BioDelivery Sciences International
BDSI
|
436 | - | -4.8 % | $ 255 M | ||
|
Catalyst Biosciences
CBIO
|
410 | $ 12.21 | -3.48 % | $ 804 M | ||
|
Aeterna Zentaris
AEZS
|
115 | - | 5.93 % | $ 314 M | ||
|
BeiGene, Ltd.
BGNE
|
49.5 | - | 0.49 % | $ 251 B | ||
|
Biogen
BIIB
|
402 | $ 191.78 | -1.72 % | $ 28.1 B | ||
|
Bellicum Pharmaceuticals
BLCM
|
6.09 | - | -9.72 % | $ 5.89 M | ||
|
Baudax Bio
BXRX
|
126 | - | 0.59 % | $ 63 K | ||
|
Aptinyx
APTX
|
46.9 | - | -39.0 % | $ 4.57 M | ||
|
Aridis Pharmaceuticals
ARDS
|
59 | - | 17.91 % | $ 11.1 M | ||
|
Amneal Pharmaceuticals
AMRX
|
123 | $ 14.64 | -0.17 % | $ 4.52 B |